These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27646589)

  • 61. [Preparation of immunoaffinity column of zearalenone].
    Zhang Y; Huang ZB; Deng SZ; Xu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Mar; 41(2):110-3. PubMed ID: 17605236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
    Josephson CD; Mullis NC; Van Demark C; Hillyer CD
    Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable Immunodeficiency.
    Fischer MB; Wolfram W; Binder CJ; Böhmig GA; Wahrmann M; Eibl MM; Wolf HM
    Front Immunol; 2015; 6():211. PubMed ID: 25999949
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
    Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
    Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
    Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin.
    Reipert BM; Stellamor MT; Poell M; Ilas J; Sasgary M; Reipert S; Zimmermann K; Ehrlich H; Schwarz HP
    Vox Sang; 2008 May; 94(4):334-41. PubMed ID: 18266779
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aβ anti-idiotypic antibodies are present in intravenous immunoglobulin and are produced in mice following its administration.
    Loeffler DA; Klaver AC; Coffey MP
    Autoimmunity; 2015 Jun; 48(4):196-200. PubMed ID: 25392130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome.
    Arnout J; Spitz B; Wittevrongel C; Vanrusselt M; Van Assche A; Vermylen J
    Thromb Haemost; 1994 Jun; 71(6):741-7. PubMed ID: 7974342
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison between tube test and automated column agglutination technology on VISION Max for anti-A/B isoagglutinin titres: A multidimensional analysis.
    Nam M; Hur M; Lee H; Kim H; Park M; Moon HW; Yun YM
    Vox Sang; 2022 Mar; 117(3):399-407. PubMed ID: 34318939
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Isoantibodies in immunoglobulin for intravenous use may cause erythrocyte sequestration.
    Shoham-Kessary H; Gershon H
    Vox Sang; 1999; 77(1):33-9. PubMed ID: 10474088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of isoagglutinin titer in ABO-incompatible kidney transplantation.
    Won D; Choe W; Kim HJ; Kwon SW; Han DJ; Park SK
    J Clin Apher; 2014 Oct; 29(5):243-50. PubMed ID: 24375675
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemolytic anemia associated with intravenous immunoglobulin.
    Wilson JR; Bhoopalam H; Fisher M
    Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Haemolysis after treatment with intravenous immunoglobulin due to anti-A.
    Morgan S; Sorensen P; Vercellotti G; Zantek ND
    Transfus Med; 2011 Aug; 21(4):267-70. PubMed ID: 21605202
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity.
    Thorpe SJ; Fox BJ; Dolman CD; Lawrence J; Thorpe R
    Vox Sang; 2003 Aug; 85(2):80-4. PubMed ID: 12925158
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies.
    Klaver AC; Coffey MP; Smith LM; Loeffler DA
    Immunol Lett; 2013; 154(1-2):7-11. PubMed ID: 23928186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution.
    Reipert BM; Ilas J; Carnewal C; Füreder SF; Bölzlbauer U; Teschner W; Fiedler C; Schwarz HP
    Vox Sang; 2006 Oct; 91(3):256-63. PubMed ID: 16958839
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
    Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.